Scarica l'app Stockscreener
1.56
3.11%
-0.05
Dopo l'orario di chiusura:
1.56
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.61
Aprire:
$1.62
Volume 24 ore:
1.69M
Relative Volume:
1.13
Capitalizzazione di mercato:
$107.18M
Reddito:
$832.00K
Utile/perdita netta:
$-135.12M
Rapporto P/E:
-0.2562
EPS:
-6.09
Flusso di cassa netto:
$-124.69M
1 W Prestazione:
-7.69%
1M Prestazione:
-28.44%
6M Prestazione:
+7.59%
1 anno Prestazione:
-25.36%
Intervallo 1D:
$1.545
$1.67
Intervallo di 1 settimana:
$1.49
$1.72
Portata 52W:
$1.30
$2.9789
Inovio Pharmaceuticals Inc Stock (INO) Company Profile
Nome
Inovio Pharmaceuticals Inc
Settore
Industria
Telefono
(858) 410-3134
Indirizzo
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA
Confronta INO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INO
Inovio Pharmaceuticals Inc
|
1.56 | 110.61M | 832.00K | -135.12M | -124.69M | -6.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-09 | Iniziato | Piper Sandler | Overweight |
| 2024-05-14 | Iniziato | Stephens | Overweight |
| 2024-01-25 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2022-11-09 | Downgrade | Maxim Group | Buy → Hold |
| 2022-11-01 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-07-19 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2022-05-11 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-01-21 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2021-12-29 | Ripresa | Jefferies | Hold |
| 2021-09-10 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-06-24 | Iniziato | Jefferies | Hold |
| 2021-03-23 | Iniziato | BofA Securities | Neutral |
| 2021-02-12 | Iniziato | Oppenheimer | Outperform |
| 2020-11-17 | Downgrade | ROTH Capital | Neutral → Sell |
| 2020-11-10 | Aggiornamento | ROTH Capital | Sell → Neutral |
| 2020-09-28 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2020-09-28 | Aggiornamento | Maxim Group | Hold → Buy |
| 2020-07-01 | Downgrade | Maxim Group | Buy → Hold |
| 2020-07-01 | Downgrade | ROTH Capital | Neutral → Sell |
| 2020-06-29 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2020-06-26 | Downgrade | Stifel | Buy → Hold |
| 2020-05-21 | Iniziato | The Benchmark Company | Buy |
| 2020-04-30 | Downgrade | ROTH Capital | Buy → Neutral |
| 2020-03-13 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-03-13 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-12-19 | Iniziato | ROTH Capital | Buy |
| 2018-02-15 | Reiterato | Maxim Group | Buy |
| 2017-10-18 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-09-06 | Iniziato | Citigroup | Buy |
| 2017-06-08 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2017-05-24 | Reiterato | Maxim Group | Buy |
| 2017-03-16 | Aggiornamento | Maxim Group | Hold → Buy |
| 2017-03-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
Mostra tutto
Inovio Pharmaceuticals Inc Borsa (INO) Ultime notizie
Inovio Pharmaceuticals: Speculative Buy Thesis Hinges On INO-3107 (NASDAQ:INO) - Seeking Alpha
Will Inovio Pharmaceuticals Inc. (GBM) stock announce special dividend2025 Investor Takeaways & Low Risk Growth Stock Ideas - ulpravda.ru
Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors - 富途牛牛
Why retail investors pile into Inovio Pharmaceuticals Inc. stockJuly 2025 Decliners & Real-Time Buy Zone Alerts - ulpravda.ru
Retail Trends: Will Inovio Pharmaceuticals Inc. (GBM) stock announce special dividendMarket Performance Recap & Daily Price Action Insights - ulpravda.ru
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc.INO - PR Newswire
AstraZeneca pullback hits Inovio shares - The Pharma Letter
Looking Into Inovio Pharmaceuticals Inc's Recent Short Interest - Sahm
INOVIO announces pricing of $25M public offering - MSN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio ... - Bluefield Daily Telegraph
Upcoming Events - FinancialContent
Inovio Pharmaceuticals Inc Stock Analysis and ForecastDividend Stability Analysis & Small Budget Capital Growth - Early Times
Ksolves India Limited Bounces Off Moving Average SupportStock Correlation Metrics & Superior Return Stocks - earlytimes.in
Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch
FDA sets 2026 decision clock for INOVIO’s rare disease therapy - MSN
U.S., U.K. Strike Drug Pricing Deal Aimed at Ending Transatlantic Imbalance - MyChesCo
INOVIO Reports Inducement Grant Under Inducement Plan - Eastern Progress
RSI Check: Will Inovio Pharmaceuticals Inc GBM stock announce special dividendEarnings Recap Summary & Free Verified High Yield Trade Plans - moha.gov.vn
FDA Sets 2026 Decision Clock for INOVIO’s Rare Disease Therapy - MyChesCo
Inovio respiratory DNA drug candidate shows promise in early trial - MSN
Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch
Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Inovio drops as respiratory papillomatosis asset denied accelerated review - MSN
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Jefferies reiterates Hold on Inovio stock amid FDA review uncertainty By Investing.com - Investing.com Canada
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - FinancialContent
Inovio stock plummets 25% after FDA denies accelerated review for lead drug candidate - The Business Journals
INOVIO’s DNA therapy for rare throat disease gets FDA review - Indian Pharma Post
Inovio Pharmaceuticals stock steady as FDA accepts BLA for INO-3107 - Investing.com Canada
Boston Herald - FinancialContent
FDA accepts Inovio’s BLA for INO-3107 review - MSN
FDA setback gives Inovio a headache - The Pharma Letter
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Why Is Inovio Pharma Stock Sinking Monday?Inovio Pharmaceuticals (NASDAQ:INO) - Benzinga
Inovio (INO) Shares Plummet 21% After FDA Review Update - GuruFocus
Inovio stock tumbles after FDA questions accelerated approval path By Investing.com - Investing.com Australia
Inovio stock tumbles after FDA questions accelerated approval path - Investing.com India
Inovio Pharmaceuticals Inc: Not Currently Pla - 富途牛牛
EBIT per share of Inovio Pharmaceuticals, Inc. – BIVA:INO - TradingView — Track All Markets
INOVIO (INO) Seeks Accelerated Approval for INO-3107 from FDA - GuruFocus
INOVIO Pharmaceuticals, Inc. Announces FDA Acceptance of BLA for INO-3107 - TradingView — Track All Markets
FDA accepts INOVIO’s BLA for RRP treatment, sets October 2026 target date - Investing.com UK
Rare throat disease may get a new non-surgical treatment option - Stock Titan
INOVIO Issues Equity Award to New Hire as It Rebuilds for Its Next Act - MyChesCo
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
INO (Inovio Pharmaceuticals) EV-to-OCF : -1.30 (As of Dec. 22, 2025) - GuruFocus
Sentiment Review: Is AMODW stock attractive for long term wealth buildingGap Down & Expert Approved Momentum Ideas - moha.gov.vn
Published on: 2025-12-22 07:17:12 - moha.gov.vn
INOVIO Advances Toward First Commercial Product as BLA Filing Caps Pivotal Quarter - MSN
Published on: 2025-12-21 00:43:45 - Улправда
Inovio Pharmaceuticals Inc Azioni (INO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):